🦠CDC Sets Roadmap for Accelerated HCV Diagnosis and Treatment
Establishing a Road Map for Accelerated Diagnosis and Treatment of HCV Infection in the United States
Summary
The Centers for Disease Control and Prevention (CDC) announces a two-day convening hosted and facilitated by the Association of Public Health Laboratories (APHL) to discuss hepatitis C diagnostics. Leaders from public health, laboratory, medical, academic, and industry sectors will have the opportunity to provide individual input, without building a consensus, on accelerating the diagnosis of current hepatitis C virus (HCV) infection. Members of the public with interest and expertise in diagnosing HCV infection are also invited to provide individual input. Specifically, the convening will focus on how to leverage the following hepatitis C diagnostic methods: same-day diagnosis and treatment, and viral-first testing.
Agencies
- Health and Human Services Department
- Centers for Disease Control and Prevention
Business Impact
$$ - Med
The notice discusses an event convening key stakeholders to address hepatitis C virus (HCV) diagnostics, which has regulatory implications for diagnostic testing companies and health service providers. The opportunity for public comment on testing regulations may influence compliance requirements and operational strategies for businesses in the healthcare sector.